Familial Cancer

, Volume 6, Issue 1, pp 141–145 | Cite as

A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene

  • M. Vernez
  • P. Hutter
  • C. Monnerat
  • N. Halkic
  • O. Gugerli
  • H. Bouzourene
Case Report

Abstract

Muir-Torre syndrome (MTS) is a rare cancer-predisposing syndrome that is autosomal dominantly inherited and characterized by the development of sebaceous skin lesions (adenomas, epitheliomas, basaliomas and carcinomas). These lesions are typically associated with tumors that belong to the spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) (i.e. tumors of the colorectum, endometrium, stomach or ovary). Biliary malignancy in association with MTS has only rarely been reported. We report a case of Muir-Torre syndrome associated with intrahepatic cholangiocarcinoma, a location not previously described, and associated with a novel missense mutation of the MSH2 gene (c.2026T > C), predicted to disrupt the function of the gene.

Keywords

Cholangiocarcinoma HNPCC Muir-Torre syndrome MSH2 Sebaceous epithelioma 

Abbreviations

CEA

carcino embryonic antigen

HNPCC

hereditary non polyposis colon cancer

MTS

Muir-Torre syndrome

MRI

magnetic resonance imaging

MSI

microsatellite instability

References

  1. 1.
    Muir EG, Bell AJ, Barlow KA (1967) Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 54:191–195PubMedGoogle Scholar
  2. 2.
    Torre D (1968) Multiple sebaceous tumors. Arch Dermatol 98:549–551PubMedCrossRefGoogle Scholar
  3. 3.
    Schwartz RA, Torre DP (1995) The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33:90–104PubMedCrossRefGoogle Scholar
  4. 4.
    Ponti G, Ponz de Leon M, Maffei S et al (2005) Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 68:442–447PubMedCrossRefGoogle Scholar
  5. 5.
    Honchel R, Halling KC, Schaid DJ et al (1994) Microsatellite instability in Muir-Torre syndrome. Cancer Res 54:1159–1163PubMedGoogle Scholar
  6. 6.
    Pedroni M, Sala E, Scarselli A et al (2001) Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 61:896–899PubMedGoogle Scholar
  7. 7.
    Mangold E, Pagenstecher C, Leister M et al (2004) A genotype–phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 41:567–572PubMedCrossRefGoogle Scholar
  8. 8.
    Akhtar S, Oza KK, Khan SA et al (1999) Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 41:681–686PubMedCrossRefGoogle Scholar
  9. 9.
    Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257PubMedGoogle Scholar
  10. 10.
    Iaccarino I, Marra G, Palombo F et al (1998) hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha. EMBO J 17:2677–2686PubMedCrossRefGoogle Scholar
  11. 11.
    Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4:245–248PubMedCrossRefGoogle Scholar
  12. 12.
    Mecklin JP, Järvinen HJ, Virolainen M (1992) The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 69:1112–1114PubMedCrossRefGoogle Scholar
  13. 13.
    Khan SA, Thomas HC, Davidson BR et al (2005) Cholangiocarcinoma. The Lancet 366:1303–1314CrossRefGoogle Scholar
  14. 14.
    Kuo CM, Changchien CS, Wu KL et al (2005) Mucin-producing cholangiocarcinoma: clinical experience of 24 cases in 16 years. Scand J Gastroenterol 40:455–459PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2006

Authors and Affiliations

  • M. Vernez
    • 1
  • P. Hutter
    • 2
  • C. Monnerat
    • 3
  • N. Halkic
    • 4
  • O. Gugerli
    • 5
  • H. Bouzourene
    • 1
  1. 1.Department of Pathology, Institut Universitaire de PathologieLausanne University HospitalLausanneSwitzerland
  2. 2.Division of Medical GeneticsICHVSionSwitzerland
  3. 3.Department of GeneticsLausanne University HospitalLausanneSwitzerland
  4. 4.Department of SurgeryLausanne University HospitalLausanneSwitzerland
  5. 5.Department of DermatologyLausanne University HospitalLausanneSwitzerland

Personalised recommendations